Cargando…
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
The pharmacological interventions available for individuals in the early stages of psychosis are extremely limited. For those at clinical high risk for psychosis, there is no licensed treatment available. For those with first-episode psychosis, all licensed antipsychotic medications act via dopamine...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110455/ https://www.ncbi.nlm.nih.gov/pubmed/34255100 http://dx.doi.org/10.1007/s00213-021-05905-9 |